Search for Clinical Trial Results

Sponsored By

Malignant Peripheral Nerve Sheath Tumor - 15 Studies Found

Status Study
Completed Study Name: Multi-Institutional Registry for Malignant Peripheral Nerve Sheath Tumors
Condition: Malignant Peripheral Nerve Sheath Tumors
Date: 2017-04-13
Terminated Study Name: Imatinib Mesylate Treatment of Patients With Malignant Peripheral Nerve Sheath Tumors
Condition: Malignant Peripheral Nerve Sheath Tumors
Date: 2007-01-25
Interventions: Drug: imatinib mesylate
Completed Study Name: A Study of Pembrolizumab in Patients With Malignant Peripheral Nerve Sheath Tumor (MPNST), Not Eligible for Curative Surgery
Condition: Malignant Peripheral Nerve Sheath Tumour (MPNST)
Date: 2016-02-04
Interventions: Drug: Pembrolizumab Other Name: Keytruda
Completed Study Name: PLX3397 Plus Sirolimus in Unresectable Sarcoma and Malignant Peripheral Nerve Sheath Tumors
Condition:
  • Sarcoma
  • Malignant Peripheral Nerve Sheath Tumors

Date: 2015-10-21
Interventions:
  • Drug: PLX3397 PLX3397 is a sel
Active, not recruiting Study Name: SARC023: Ganetespib and Sirolimos in Patients With MPNST (Malignant Peripheral Nerve Sheath Tumors)
Condition:
  • Malignant Peripheral Nerve Sheath Tumors (MPNST)
  • Sarcoma
    • <
    Date: 2013-11-25
    Interventions:
    • Drug: ganetespib 200 mg/m²
Completed Study Name: Vaccine Therapy in Treating Patients With Malignant Peripheral Nerve Sheath Tumor That is Recurrent or Cannot Be Removed by Surgery
Condition:
  • Metastatic Malignant Peripheral Nerve Sheath Tumor
  • Neurofibroma
    Date: 2016-02-25
    Interventions:
    • Procedure: Computed Tomography

Active, not recruiting Study Name: SARC016: Study of Everolimus With Bevacizumab to Treat Refractory Malignant Peripheral Nerve Sheath Tumors
Condition:
  • Malignant Peripheral Nerve Sheath Tumors
  • MPNST
  • Drug: everolimus 10 mg tablet

Active, not recruiting Study Name: Lorvotuzumab Mertansine in Treating Younger Patients With Relapsed or Refractory Wilms Tumor, Rhabdomyosarcoma, Neuroblastoma, Pleuropulmonary Blastoma, Malignant Peripheral Nerve Sheath Tumor, or Synovial Sarcoma
Condition:
  • Pleuropulmonary Blastoma
  • Recurrent Malignant Peripheral Nerve Sheath T
    Date: 2015-05-20
    Interventions:
    • Other: Laboratory Biomarker Analysis

Completed Study Name: S0330 Erlotinib in Treating Patients With Unresectable or Metastatic Malignant Peripheral Nerve Sheath Tumor
Condition: Sarcoma
Date: 2003-09-10
Interventions: Drug: erlotinib hydrochloride 150 mg per day, daily until disease progression
Completed Study Name: Combination Chemotherapy in Treating Patients With Stage III or Stage IV Malignant Peripheral Nerve Sheath Tumors
Condition:
  • Neurofibromatosis Type 1
  • Sarcoma

Date: 2006-03-15
Interventions:
  • Biological: filgrastim Given s
Next >>>